Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis
Robert N RubeyRetired, Red Lodge, Montana, USAAbstract: There is a growing body of evidence that implicates the herpes simplex type 1 virus (HSV-1) in the development of Alzheimer’s dementia (AD). HSV-1 has been found to be present in the cerebrum of the great majority of older adults,...
Guardado en:
Autor principal: | Robert N Rubey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c148f4d35b4848958bcd7e60a007ec43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Jennifer L Reingold, et al.
Publicado: (2007) -
An update on the toxicity of Aβ in Alzheimer’s disease
por: Jürgen Götz, et al.
Publicado: (2008) -
Update on the use of memantine in Alzheimer’s disease
por: Robert J van Marum
Publicado: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012) -
Brain amyloid β protein and memory disruption in Alzheimer’s disease
por: Weiming Xia
Publicado: (2010)